FDA Adverse Event Injury Summary report: N

EON MINI IPG, 16-CHANNEL RECHARGEABLE

MDR report key: 2010933 · Received March 4, 2011

Report

Report Number
1627487-2011-00284
Event Type
Injury
Date Received
March 4, 2011
Date of Event
July 30, 2010
Report Date
May 18, 2015
Manufacturer
ST JUDE MEDICAL - NEUROMODULATION DIV.
Product Code
LGW
PMA / PMN Number
P010032
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). SJM HAS LIMITED INFORMATION RELATED TO THE PATIENT'S MEDICAL HISTORY AND IS UNABLE TO FORM AN OPINION AS TO THE RELEVANCY OF THE PATIENT'S HISTORY TO THE EVENT REPORTED. SJM DEFERS TO THE PATIENT'S PHYSICIAN REGARDING MEDICAL HISTORY.

Additional Manufacturer Narrative · 1

SJM HAS LIMITED INFO RELATED TO THE PT'S MEDICAL HISTORY AND IS UNABLE TO FORM AN OPINION AS TO THE RELEVANCY OF THE PT'S HISTORY TO THE EVENT REPORTED. SJM DEFERS TO THE PT'S PHYSICIAN REGARDING MEDICAL HISTORY.

Description of Event or Problem · 1

DEVICE 1 OF 2 REFERENCE MFR REPORT # 1627487-2015-00039 A REVIEW OF THE PATIENT'S MEDICAL RECORD INDICATED THAT PRIOR TO THE EXPLANT AND REPLACEMENT OF THE IPG, THE PATIENT EXPERIENCED LEAD MIGRATION IN (B)(6) 2009 AFTER MOVING A LARGE OBJECT. SURGICAL INTERVENTION WAS UNDERTAKEN ON (B)(6) 2009 TO EXPLANT AND REPLACE THE PATIENT¿S LEADS (FROM THE SAME LOT) AND REVISE THE IPG. IT WAS NOTED DURING THE PROCEDURE THE PHYSICIAN IDENTIFIED A FRACTURE IN ONE OF THE LEADS. AN ADDITIONAL REPORT IS BEING SUBMITTED FOR THE PATIENT'S LEADS.

Description of Event or Problem · 1

THE PT WAS IMPLANTED WITH AN IPG ON (B)(6) 2009. IT WAS REPORTED THAT THE PT FELT A BURNING SENSATION AT THE IPG SITE WHEN HER STIMULATION WAS IN USE. IN AN EFFORT TO RESOLVE THIS MATTER, THE PT'S IPG WAS REPLACED ON (B)(6) 2010.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 EON MINI IPG, 16-CHANNEL RECHARGEABLE TOTALLY IMPLANTABLE PULSE GENERATOR LGW ST JUDE MEDICAL - NEUROMODULATION DIV. 3788 2803493

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention